Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

Detalles Bibliográficos
Autores principales: Liu, Yang, Yan, Fangfang, Jiang, Vivian Changying, Li, Yijing, Che, Yuxuan, McIntosh, Joseph, Jordan, Alexa, Hou, Ian, Nie, Lei, Jin, Jingling, Wang, Wei, Lee, Heng-Huan, Yao, Yixin, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153528/
https://www.ncbi.nlm.nih.gov/pubmed/36475521
http://dx.doi.org/10.3324/haematol.2022.282031
Descripción
Sumario:

Ejemplares similares